----
Current ValuationThe current P/E ratio is 61.72, above the reasonable range, cheaper than 18.57% of the time in the past 5 years, and the industry ranks 26/84, the industry Median 20.41.
61.72xP/E
¥29.47Stock price
¥0.48Earnings per share
61.72xP/E
Stock price¥29.47Earnings per share¥0.48
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 42.67x
- Typical range
- 31.05x–61.10x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 20.41x
022446688
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 20.41x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
301080SZACROBIOSYSTEMS | 70.23x | 38.72% | ¥13.68B |
301047SZSino Biological | 67.40x | 37.49% | ¥12.07B |
600645SHVCANBIO | 71.44x | -- | ¥8.04B |
688366SHHAOHAI BIOTEC | 61.72x | -- | ¥6.74B |
688163SHSHANGHAI SERUM BIO-TECHNOLOGY | 62.35x | -- | ¥3.16B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
